Medical device for agent delivery and related use method

Abstract

To simply and quickly achieve delivery of a hemostatic agent as one example.SOLUTION: A medical system is disclosed. The system includes a medical device including a catheter, a medicine delivery device arranged outside the medical device and fluidly coupled to the catheter, and a fluid delivery device arranged outside the medical device and fluidly coupled to the catheter. The medicine delivery device is configured to store medicines and is configured to deliver the medicines into the catheter toward the medial device. The fluid delivery device is configured to store the fluid and is configured to delivery the fluid into the catheter toward the medical device. The medical device is configured to be able to deliver the medicines received from the medicine delivery device and the fluid received from the fluid delivery device by the medical device toward a target tissue through the catheter when a distal end of the catheter is arranged at the target tissue.SELECTED DRAWING: Figure 1

Description

[Technical field]

[0001] FIELD OF THE DISCLOSURE The present disclosure relates generally to medical systems and devices for delivering pressurized fluids / agents, and more particularly to devices, methods and apparatus for delivering fluids / agents through channels of medical devices. [Background technology]

[0002] Some medical procedures may require stopping or minimizing bleeding within the body. For example, endoscopic medical procedures may require hemostasis of bleeding tissue within the gastrointestinal tract, such as in the esophagus, stomach, or intestines.

[0003] During an endoscopic procedure, a user inserts the sheath of the endoscope into a body lumen of a patient. The user controls the endoscope during the procedure using the handle of the endoscope. Instruments are passed through the working channel of the endoscope, for example, via ports in the handle, to perform treatment at a treatment site near the distal end of the endoscope, the treatment site being remote from the operator.

[0004] To achieve hemostasis at a remote site, a hemostatic drug may be delivered by a device inserted into the working channel of an endoscope. Drug delivery may be achieved, for example, by a mechanical system. However, such systems may require multiple steps or actuations to achieve delivery, lengthen procedure times, not achieve a desired rate of delivery of the drug or a desired dosage of the drug, require the user to reposition the endoscope to allow the device to pass through the working channel, cause portions of the delivery device to become clogged with the drug, provide inconsistent drug dosage, or fail to reach a treatment site deep in the Gl duct. The present disclosure may solve one or more of these problems or other problems in the art. Summary of the Invention

[0005] Examples of the present disclosure relate, inter alia, to drug delivery devices. Each of the examples disclosed herein may include one or more of the features described in connection with the disclosed examples. The delivery device may be configured to deliver a drug to a target tissue through a channel of a medical device. The delivery device may include a body, a drug source, and a pressurized fluid source. The body may include (a) a coupling region configured to removably attach to a handle of the medical device, and (b) a coupler including an outlet port for alignment with a port of the channel, the coupler configured to be connected to the port of the channel. The body, drug source, and pressurized fluid source may be arranged to deliver the drug and pressurized fluid through the channel to the outlet port for delivery.

[0006] Any of the systems and devices disclosed herein may have any of the following features: The coupling region may include a U-shaped surface configured to connect with a handle of a medical device. The U-shaped surface may include contours to inhibit movement between the U-shaped surface and the handle of the medical device. The coupling region may be configured to snap onto the handle of the medical device. The coupling region may include a strap configured to wrap around the handle of the medical device. The handle of the medical device may be a first handle and the body may include a second handle. The second handle may include an interior configured to receive a pressurized fluid container. When the delivery device is coupled to the first handle, a longitudinal axis of the second handle may extend generally parallel to a longitudinal axis of the first handle. When the delivery device is coupled to the first handle, the second handle may be spaced apart from the first handle. The second handle may include a plurality of grooves. The grooves may be configured to accommodate the fingers of a user's hand and an axis extending through the grooves may be generally parallel to an axis of the first handle. The coupler may be configured to form a fluid-tight seal with the port of the channel such that the outlet port is fluidly connected to the channel. The coupler may be a press-fit coupler configured to press-fit into the port to form a fluid-tight seal with the port. The coupler may be a first coupler and the outlet port may be a first outlet port. Therewith, the device may further include a first catheter fluidly coupled at a first end to the first coupler, a Y-connector fluidly coupled to a second end of the first catheter, a syringe fluidly coupled to the Y-connector, and a second coupler including a second outlet port for alignment with the port of the channel. The second outlet port may be fluidly connected to the first catheter, the Y-connector, and the syringe. The second coupler may be configured to connect with the port of the channel. The device may further include a second catheter, the second catheter including a third coupler, the second catheter fluidly connected to the Y-connector and coupled to the second coupler, the third coupler configured to couple with the port of the channel.The handle of the medical device can be a first handle and the body can include a first proximal portion including the second handle, a first distal portion, and a second proximal portion including the coupling region. The first proximal portion, the second proximal portion, and the first distal portion can form a U-shape.

[0007] The delivery device may be configured to deliver a drug to a target tissue through a channel of a medical device. The delivery device may include 1) a body. The body may include (a) a coupling region configured to removably attach to a handle of a medical device and (b) a coupler including an outlet port for alignment with a port of the channel, the coupler being configured to connect with the port of the channel. The delivery device may include 2) an enclosure within the body. The enclosure is configured to store a drug, receive a pressurized fluid, and release a combination of the pressurized fluid and the drug through the outlet port. The delivery device may include 3) a regulator within the body and configured to control delivery of the pressurized fluid to the enclosure. The regulator includes a fluid input port, and upon coupling a pressurized fluid container to the fluid input port, the pressurized fluid and the drug flow from the enclosure to the outlet port.

[0008] Any of the systems and devices disclosed herein may have a total volume of pressurized fluid within the pressurized fluid reservoir and are configured to deploy a preset amount of drug through the channel.

[0009] In another example, a system is configured to deliver a drug to a target tissue through a channel of a medical device. The system may include a medical device including a handle, a channel, and a port at an end of the channel, and a delivery device. The delivery device may include a body, a drug source, and a pressurized fluid source. The body includes (a) a coupling region configured to removably attach to the handle, and (b) a coupler including an exit port for alignment with the port. The coupler is configured to connect with the port. The body, drug source, and pressurized fluid source may be arranged to deliver the drug and pressurized fluid to the exit port and the channel for delivery to the target tissue.

[0010] Any of the systems and devices disclosed herein may have any of the following features: The delivery device may be configured to deliver a drug and a pressurized fluid through the channel such that the drug contacts an inner surface of the channel. The system or device may include a liner that covers an outer surface of the medical device and an inner surface of the channel.

[0011] It will be understood that both the foregoing summary and the following detailed description are exemplary and explanatory only and are not limiting of the invention as claimed. As used herein, the terms "comprises," "comprising," or any other variations thereof are intended to cover a non-exclusive inclusive, and a process, method, article, or device that includes a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or device. The term "exemplary" is used in the sense of "example" rather than "ideal." The term "approximately" or similar terms (e.g., "generally") include values ​​of ±10% of the stated value. The term "distal" refers to the portion of the device that is furthest from the user when the device is introduced into the patient's body. In contrast, the term "proximal" refers to the portion of the device that is closest to the user when the device is placed in the patient's body. The proximal and distal directions may be labeled with arrows marked with "P" and "D," respectively, throughout the drawings.

[0012] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and, together with the description, serve to explain the principles of the disclosed embodiments. [Brief description of the drawings]

[0013] [Figure 1] FIG. 2 is a side view of a delivery system according to an exemplary embodiment. [Diagram 2] FIG. 2 is a side view of a delivery system according to an exemplary embodiment. [Diagram 3] FIG. 2 is a side view of a delivery system according to an exemplary embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] The drug delivery device used in the exemplary embodiments may be configured to store the drug within the housing of the delivery device and to control the rate at which the drug and fluid exit the delivery device. The delivery device may be configured to store a single component drug or a multi-component drug. In the case of a multi-component drug, the delivery device may be configured to allow mixing of the multiple components prior to delivery from the device. Various mechanisms may be used to pre-pressurize the drug chamber and actuate the delivery device to deliver the drug. These mechanisms may include air pressure, wires, tubes, valves, or any suitable combination thereof. Such drug delivery devices may be configured to couple to a primary medical device and may cooperate with the primary medical device to deliver the drug to a target tissue. Some embodiments of the delivery device combined with a primary medical device, such as one already positioned at a target site in a body lumen, may facilitate delivery of a hemostatic drug to a target tissue within a patient's body through a channel of the medical device.

[0015] Referring to FIG. 1, a delivery system 100 according to an embodiment is shown. The delivery system 100 may include a medical device 101 and a delivery device 102. The medical device 101 may be considered the primary medical device, and the delivery device 102 may be configured to be coupled to and operate with the medical device 101. The medical device 101 may be an endoscope, a ureteroscope, a hysteroscope, a bronchoscope, a colonoscope, a cystoscope, or any other medical device known in the art having a channel therethrough. The medical device 101 may include a handle 103, a catheter 107, one or more operating knobs 119, 121, one or more valves / actuators 115, 117, and an umbilicus 105. The channel 125 may be a working channel and may extend distally from the proximal port 123 through a portion of the handle 103 and through the catheter 107 to a distal opening 111 at the distal end 109. The channel 125 may be configured to receive one or more instruments, fluids, and / or suction provided at the proximal port 123 or through the umbilical cord 105. In some examples, the medical device 101 may include an imaging portion 113 positioned at the distal end 109 of the catheter 107. In some examples, the umbilical cord 105 may be electronically connected to a controller (not shown). In conjunction, one or more actuators 115, 117 may be actuated to generate commands executed by the controller, such as initiating a fluid jet, suction, or initiating an image capture mechanism using the imaging portion 113. In some examples, the umbilical form 105 may couple one or more fluid sources and / or one or more vacuum sources to the medical device 101. In some examples, one or more knobs 119, 121 may be configured to control movement of the distal end 109 of the catheter 107.

[0016] The delivery device 102 may be configured to removably couple to the medical device 101. The delivery device 102 may include a housing 142, an enclosure 134 containing a drug 135, a fluid container 130, a regulator 132 including a fluid source input port 150, an actuator 146, a filter 148, a coupler 140, and a number of tubes 136, 138. In some examples, the fluid container 130 may release pressurized fluid into the regulator 132 when coupled to the regulator 132. For example, the input port 150 may be configured to puncture the fluid container 130 when the fluid container 130 is coupled to the regulator 132 and release pressurized fluid from the fluid container 130 into the regulator 132. These components and their functions are described below. However, these components are exemplary. For example, any of the devices and / or components thereof described in U.S. Patent Application No. 16 / 589,633, filed October 1, 2019, the contents of which are incorporated herein by reference in their entirety, may be used in embodiments.

[0017] With reference to FIG. 1 , the fluid container 130 is configured to contain a fluid, such as a gas, such as carbon dioxide or any other gas, or other fluid known in the art. The fluid container 130 is shown as a cylindrical enclosure, but may be any shape, such as a torpedo shape, a sphere, or any other shape known in the art and used to store fluids. In some examples, the fluid container 130 may be a carbon dioxide tank or cylinder, which are commonly found in medical settings, such as hospitals. The fluid container 130 may include one or more exterior walls that define one or more internal chambers (not shown), the one or more internal chambers configured to contain a fluid. The walls of the fluid container 130 may be formed of any material suitable for containing a fluid, such as, but not limited to, a metal alloy, a ceramic, or other material known in the art. The fluid contained in the internal chamber of the fluid container 130 may be under pressure. Thus, the walls are formed of a material and / or thickness suitable for containing a fluid at a pressure of at least approximately 1000 pounds per square inch (PSI), or approximately 850 PSI, for example. For example, a gas that may be contained in the fluid container 130 is carbon dioxide (CO), which has a vapor pressure of approximately 2,000-8,000 kPa at typical device temperatures. 2 ), or nitrogen (N 2 It is understood that these gases are examples and do not limit the types of gases that may be placed in the fluid enclosure 130.

[0018] Continuing with reference to FIG. 1 , the fluid container 130 is attached to the regulator 132 at a regulator input port 150. The regulator 132 includes an input port 150 and one or more output ports 151, 152. The input port 150 of the regulator 132 may be configured to pierce the fluid container 130. One or more tubes 136, 138 may fluidly couple the one or more output ports 151, 152 to the enclosure 134 and / or the coupler 140. The regulator 132 may be configured to modify the flow rate of fluid exiting the fluid container 130 such that the fluid flows through the tubes 136, 138 into the enclosure 134 and / or the coupler 140 at a selected flow rate. In some examples, the fluid may enter the enclosure 134 and / or the coupler 140 at a flow rate in the inclusive range of 4 standard liters per minute to 12 standard liters per minute of fluid flow. In some examples, the delivery device 102 may be configured to operate with fluid flowing through the enclosure 134 and / or the coupler 140 at a flow rate in the inclusive range of 5 standard liters per minute to 10 standard liters per minute.

[0019] The fluid reservoir 130 may be coupled to the regulator 132 via a pull cord coupling mechanism or a pump mechanism. In some examples, the pull cord coupling mechanism may be included in the delivery device 102 and may include an actuator including a cord and a pin. The pin may engage a fluid cartridge (such as the fluid reservoir 130) to release fluid from the cartridge when a user pulls the cord. For example, the pin may pierce the cartridge and cause pressurized fluid to flow through the device 102. In other examples, the pump mechanism may be included in the device 102 and may be configured to supply pressurized fluid to the device 102, for example, by supplying pressurized gas into the device 102. In some examples, the device 102 may not include the regulator 132, and the reservoir 130 may be directly coupled to one or more tubes 136, 138 via an input opening similar to the input opening 150.

[0020] The tube 136 may provide fluid under pressure from the fluid reservoir 130 and regulator 132 to the enclosure 134. The enclosure 134 may be cylindrical and may include an internal cavity 137 and a funnel portion 139 at an end of the enclosure 134. The enclosure 134 may be configured to store a drug 135, such as a powdered or liquid drug, in the internal cavity 137, which may be fluidly connected to the tube 136. The funnel portion 139 may include a tapered surface that forms a portion of the internal cavity 137, which leads to an opening at the end of the enclosure 134. The funnel portion 139 may be configured to direct the drug 135 through the opening into the tube 138 (branch 160 of the tube 138) and into the coupler 140. In some examples, the enclosure 134 may be configured to gravity feed the drug 135 into the tube 138 and into the coupler 140. The enclosure 134 may be of any suitable material known in the art, in some examples, the enclosure 134 may be made of a transparent material.

[0021] The tube 138 may include two branches 160, 161. The branch 160 may extend between and fluidly couple the enclosure 134 and the coupler 140. The branch 161 may extend between and fluidly couple the regulator 132 and the coupler 140. The branches 160 and 161 may meet at or just prior to the coupler 140. In some examples, the tube 138 may include a filter 148 positioned within the lumen of the tube 138. The filter 148 may be configured to allow fluid to flow distally from the regulator 132 through the lumen of the tube 138 and may also be configured to prevent the drug 135 from moving proximally through the tube 138 toward the regulator 132. The filter 148 may be configured to prevent the drug 135 from moving through the tube 138 into the regulator 132. In some examples, the filter 148 may be configured to restrict the flow of fluid through the tube 138 by narrowing the diameter of the inner lumen of the tube 138. The delivery device 102 may provide a means of delivering the drug 135 to the target tissue by using existing channels in the medical device, such as the channel 125 of the medical device 101, which may shorten procedure times and simplify procedures requiring delivery of the drug 135 to tissue.

[0022] The actuator 146 may be operatively coupled to the regulator 132 and configured to control the release of pressurized fluid from the regulator 132 into the tube 136 and / or the tube 138. The actuator 146 may include a trigger, a button, a pressure sensor, a lever, and / or any other actuation mechanism known in the art. In some examples, the actuator 146 may be configured to control the release of the medication 135 into the coupler 140 and into the channel 125 of the medical device 101 by restricting the pressurized fluid provided to the tube 136 and the enclosure 134. The actuator 146 may extend outwardly from the housing 142 to allow a user to actuate the actuator 146.

[0023] The coupler 140 may be configured to releasably couple to the port 123 of the channel 125 and fluidly connect the tube 138 with the channel 125. In some examples, the coupler 140 may form a fluid-tight seal between the port 123 and the coupler 140 such that fluid may pass through the tube 138 into the channel 125 without flowing through areas external to the medical device 101 and the delivery device 102. The coupler 140 may include one or more O-rings, which may be polymeric, rubber, metal, or any other material. In some examples, the coupler 140 may be a press-fit coupler and may form a fluid-tight seal with the port 123 to fluidly connect the tube 138 to the channel 125. In some examples, the coupler 140 may be a quick-release coupler. The coupler 140 may be a gasket seal, such as a rubber gasket seal, or a snap fit. In some examples, coupler 140 may be a deformable plastic cap that is placed over port 123 and that the user may pinch to open and release to close over port 123. Coupler 140 may include a threaded component (e.g., may include threads that may threadably mate with threads on port 123 via the threads of coupler 140 to couple to port 123) and may facilitate coupling of coupler 140 to port 123 by a geometry at the distal portion of handle 103.

[0024] Each of the enclosure 134, the fluid container 130, the regulator 132, the actuator 146, the filter 148, the coupler 140, and the tubes 136, 138 may be fully or partially housed within the housing 142. The housing 142 may be U-shaped (an upside-down "U" as shown in the drawings) and may include a proximal portion 170, a first distal portion 171, and a second distal portion 172. The first distal portion 171 (bottom right of the housing 142) may be a handle and may be configured to be held by a user using one hand. In some examples, a central longitudinal axis of the first distal portion 171 may be configured to extend parallel to a central longitudinal axis of the handle 103. In some examples, when the delivery device 102 is coupled to the handle 103, the proximal portion 170 may contact the handle 103 and extend radially outward therefrom, and the first distal portion 171 may be spaced apart from the handle 103. The first distal portion 171 may include an outer surface ergonomically shaped to accommodate one or more fingers of a user's hand. For example, each of the grooves 171a on the surface furthest from the device 101 may accommodate four fingers of an operator's other hand while the operator's hand holds the handle 103 of the device 101. A portion of the first distal portion 171 may be removable and configured to allow the fluid container 130 to be inserted into the housing 142 for coupling to the regulator 132. All or a portion of the fluid container 130 may be positioned within the first distal portion 171. In some examples, a removable cover (not shown) may be present at the proximal end of the housing 142 and may be configured to allow a user access to the enclosure 134 .

[0025] The coupling region 144 of the housing 142 may be configured to removably couple to the handle 103 of the medical device 101. In some examples, the coupling region 144 may be configured to snap onto the handle 103. The coupling region 144 may include a coupler 140 and may be configured to couple to the handle 103 such that the coupler 140 aligns with the proximal opening 123 of the channel 125. The surface receives the handle 103 of the device 101. In some examples, the coupling region 144 may include a U-shaped surface extending longitudinally in a proximal-distal direction. In some examples, the coupling region 144 may include a strap (not shown) configured to wrap around the handle 103 to couple the delivery device 102 to the handle 103. In some examples, the coupling region 144 may be configured to generate an audible sound, such as a "click" sound, when the delivery device 102 is fixedly coupled to the handle 103. In other embodiments, the inner U-shaped surface of the bonding region 144 may include friction enhancing undulations to inhibit movement between the surface and the handle 103. The bonding region 144 may include a deformable plastic component that may be deformed and return to its original state to facilitate bonding of the bonding region 144 to the handle 103. As such, the bonding region 144 may have an original state that matches the form factor of the handle 103. In some examples, the bonding region 144 may include a C-shaped surface that may be configured to snap-fit ​​and extend around the handle 103. The bonding region 144 may include a hinged portion (not shown) configured to surround the handle 103 and be bonded to a portion of the bonding region 144 once positioned around the handle 103. For example, the attachment region 144 may include a hinged portion having a first state in which the hinge is open and the attachment region 144 may be positioned about the handle, and a second state when the hinged portion extends around a portion of the handle 103 and a portion of the attachment region 144 attaches to another, distinct portion of the attachment region 144 (thereby forming a portion that extends around the handle 103). The hinged portion of the attachment region 144 may completely surround a radially outer surface that extends about the central longitudinal axis of the handle 103.In some examples, the hinged portion of the coupling region 144 may partially surround a radially outer surface of the handle 103 extending about a central longitudinal axis of the handle 103 when the coupling region 144 is coupled to the handle 103.

[0026] In operation, if the delivery device is not already loaded with the drug 135 in the enclosure 134, the user first inserts the drug 135 into the enclosure 134 of the delivery device 102. Then, in some examples, the user may couple the fluid container 130 to the regulator 132. Next, in some examples, the user may couple the delivery device 102 to the medical device 101 by pushing the coupling region 144 toward the handle 103 or by any other method described above. Then, in some examples, the user may move the delivery device 102 proximally and / or distally until the coupler 140 is fluidly coupled to the port 123 of the channel 125 in any of the methods described above. If the device 101 has not yet been inserted into the patient with the distal opening proximate to the target tissue, the user may position the distal opening 111 of the channel 125 proximate to the target tissue of the patient, for example, a target tissue within the patient's body lumen. Once the distal opening 111 is positioned proximate or at the target tissue, the user may actuate the actuator 146. By actuating the actuator 146, the regulator 132 may begin to flow fluid from the fluid container 130, through the regulator 132, and into the tube 136. The fluid may then flow from the tube 136 through the enclosure 134. As the fluid flows into the enclosure 134, the drug 135 may be moved in the direction of the fluid flow and carried through the tube 138 and the coupler 140 into the port 123 and the channel 125. The drug 135 may then be directed through the channel 125 and pushed by the fluid flow out of the distal opening 111 towards the target tissue. In some examples, after delivering the drug 135 to the target tissue, the user may disconnect the delivery device 102 from the handle 101 and clean the channel 125 by extending a wire brush or other cleaning brush through the channel 125 or by providing irrigation fluid to the channel 125. The user may then reconnect the delivery device 102 to the handle 103 and continue to deliver the drug 135 through the channel 125 to the target tissue.

[0027] In some examples, the medical device 101 may include a proximal port, for example similar to the proximal opening 123, or may include a suction channel extending through the umbilical cord 105 to a suction enclosure. To operate the delivery device 102 with such a suction channel, the user first presses the actuators 115, 117 to prevent suction through the suction channel. The user then couples the delivery device 102 to the proximal port of the working channel for delivery of the drug 135, as described above. By first turning off suction on the suction channel, thereby preventing suction through the channel 125, the user can prevent the drug 135 from coming into contact with bodily fluids and avoid clogging the channel 125 while delivering the drug 135 therethrough.

[0028] In other examples, a user may begin flowing fluid through the delivery device 102 when the fluid container 130 is coupled to the regulator 132, and the user does not need to actuate the actuator 146 or otherwise regulate the delivery of the drug 135 through the channel 125 with the flow of fluid from the fluid container 130. Actuation of the delivery device 102 by coupling the fluid container 130 to the regulator 132 (e.g., puncturing the carbon dioxide container by coupling to the regulator 132) provides a means of delivering the drug 135 to the target tissue without the need for an actuator 146, and may result in a single shot of the drug 135 to the target tissue. In some examples, the delivery device 102 may not include a regulator 107 and may not include an actuator 146. In some examples, all or most of the drug 135 may be expelled from the enclosure 134 when the fluid container 130 is coupled to the regulator 132. The volume of the fluid reservoir 130 can be configured to deliver a selected amount of the drug 135 using the delivery device 102 .

[0029] 2 illustrates an alternative embodiment of a delivery system 200 similar to delivery system 100. Delivery system 200 may include a medical device 201 and a delivery device 202. Medical device 201, like device 101, may include a handle 203, a catheter 207, and a channel 225 including a proximal opening 223. Delivery device 202, like device 102, may include a fluid reservoir 230, a regulator 232, and an enclosure 234. Any of the features described herein above with respect to delivery system 100, medical device 101, and delivery device 102 may be included in delivery system 200, medical device 201, and delivery device 202.

[0030] The delivery system 200 may also include a catheter 256 (e.g., a tube) extending from the output port 280, which may or may not include a coupler similar to coupler 138. The catheter 256 may extend from the output port 280 to a Y-connector 250, and an end of the catheter 256 may be fluidly coupled to the Y-connector 250. The Y-connector 250 may also be fluidly coupled to a second catheter 254 (e.g., a tube) extending from the Y-connector 250 to a syringe 260. The Y-connector 250 may also be fluidly coupled to a third catheter 252 (e.g., a tube) extending from the Y-connector 250 to a port 223 of the channel 225. In some examples, the end of the third catheter 252 may include a coupler similar to coupler 138 described herein above, and may be configured to fluidly couple to the port 223 of the channel 225. In other examples of the delivery system 200, the Y-connector 250 may be directly coupled to the port 223 of the channel 225 and may not include the third catheter 252.

[0031] The syringe 260 may be configured to push fluid through the second catheter 254, the Y-connector 250, the third catheter 252, and through the port 223 into the channel 225. The syringe 260 may be configured to provide fluid to flush the channel 225. In some examples, a user may send fluid into the channel 225 via the syringe 260 after delivering a drug from the delivery device 202 through the channel 225. The syringe 260 may provide a user with a means to flush the channel 225 immediately after delivering a drug from the delivery device 202 through the channel 225 to a target tissue of a patient. In some examples, the syringe 260 may be configured to facilitate removal of clogs formed in the channel 225, such as drug 135 pooled in the channel 225.

[0032] 3 illustrates an alternative embodiment of a delivery system 300. The delivery system 300 may include a medical device 301, a delivery device 302, and a syringe 360. The medical device 301 may include a handle 303, a catheter 307, and a channel 325 that includes a proximal opening 323. The delivery device 302 may include a fluid reservoir 330, a regulator 332, and an enclosure 334. Any of the features described herein above with respect to the delivery systems 100, 200, the medical devices 101, 201, and the delivery devices 102, 202 may be included in the delivery system 300, the medical device 301, and the delivery device 302.

[0033] The delivery system 300 may also include a medical device liner 370 that extends longitudinally around the catheter 307 and the distal portion of the handle 303, including the port 323. The medical device liner 370 may also extend through the channel 325, such that portions of the liner 370 are adjacent to the inner surface of the channel 325. The medical device liner 370 may encase a portion of the medical device 301, including all of the catheter 307, and cover the outer surface of that portion of the medical device 301. In some examples, the medical device liner 370 may include two cylindrical, sleeve-like portions, a first portion configured to cover an outer portion of the catheter 307 and the handle 303, and a second portion configured to cover or otherwise line the inner surface of the channel 325. The first and second portions of the device liner 370 may be connected at a distal end portion configured to cover the distal tip 309. A second portion of the device liner 370 (the portion within the channel 325) may be configured to be back-fed from the distal end 309 through the channel 325. A portion of the device liner 370 may be configured to removably couple to the port 323. The medical device liner 370 may be configured to protect an exterior portion of the medical device 301 and also protect the interior surface of the channel 325 from wear that may result from the movement of the drug through the channel 325. The medical device liner 370 may be disposable and may be made of any suitable soft material known in the art. In some examples, the medical device liner 370 may be made of one or more of a plastic, a polymer, and pebax. The liner 370 may be fastened to the proximal opening 323 by heat shrinking, reflowing a plastic component, or a barb fitting.

[0034] Unless otherwise specified, the structural elements of the medical devices 101, 201, 301 and delivery devices 102, 202, 302 may be of any material known in the art, including, but not limited to, metal alloys, ceramics, and / or resins.

[0035] (Additional Note) As a preferred embodiment, the technical ideas that can be understood from the above embodiment will be described below. [Item 1] A delivery device configured to deliver a drug to a target tissue through a channel of a medical device, comprising: The delivery device comprises a body including: (a) a coupling region configured to removably attach to a handle of the medical device; and (b) a coupler including an exit port for alignment with a port of the channel, the exit port of the coupler configured to connect with the port of the channel; the delivery device comprising a drug source defined by a cylindrical portion and a funnel portion located at a lower end of the cylindrical portion, the cylindrical portion configured to store a drug and the funnel portion configured to receive the drug from the cylindrical portion by gravity; the delivery device comprises a pressurized fluid source, the body, the drug source, and the pressurized fluid source being arranged to deliver pressurized fluid into the drug source and move a mixture of the drug and the pressurized fluid out of the drug source and to the outlet port of the coupler for delivery through the channel; Delivery device. [Item 2] Item 14. The delivery device of item 1, wherein the coupling region comprises a U-shaped surface configured to connect with a handle of the medical device. [Item 3] 3. The delivery device of claim 2, wherein the U-shaped surface includes undulations to inhibit movement between the U-shaped surface and the handle of the medical device. [Item 4] Item 1 , the delivery device according to item 1 , wherein the coupling region is configured to snap-fit ​​onto the handle of the medical device. [Item 5] Item 1 , the delivery device of item 1 , wherein the attachment region comprises a strap configured to wrap around the handle of the medical device. [Item 6] Item 1 , the delivery device of item 1 , wherein the handle of the medical device is a first handle and the body includes a second handle. [Item 7] 7. The delivery device of claim 6, wherein the second handle includes an interior configured to receive a pressurized fluid container. [Item 8] 7. The delivery device of claim 6, wherein a longitudinal axis of the second handle extends generally parallel to a longitudinal axis of the first handle when the delivery device is coupled to the first handle. [Item 9] 7. The delivery device of claim 6, wherein the second handle is spaced from the first handle when the delivery device is coupled to the first handle. [Item 10] 7. The delivery device of claim 6, wherein the second handle includes a plurality of grooves configured to accommodate the fingers of a user's hand, and an axis extending through the plurality of grooves is generally parallel to an axis of the first handle. [Item 11] 11. The delivery device of any one of items 1 to 10, wherein the coupler is configured to form a fluid-tight seal with the port of the channel such that the outlet port is fluidly connected to the channel. [Item 12] 12. The delivery device of any one of items 1 to 11, wherein the coupler is a press-fit coupler configured to press-fit into the port to form a fluid-tight seal with the port. [Item 13] the coupler is a first coupler and the exit port is a first exit port; The delivery device further comprises a first catheter, the first catheter fluidly coupled at a first end to the first outlet port of the first coupler; The delivery device further comprises a Y-connector, the Y-connector fluidly coupled to a second end of the first catheter; The delivery device further comprises a syringe, the syringe being fluidly coupled to the Y-connector; the delivery device comprises a second coupler, the second coupler including a second outlet port for alignment with a port of the channel, the second outlet port being fluidly connected to the first catheter, the Y-connector, and the syringe, the second outlet port of the second coupler being configured to connect with the port of the channel of the medical device. Item 1. The delivery device of item 1. [Item 14] Item 14. The delivery device of item 13, further comprising a second catheter, the second catheter including a third coupler, the second catheter fluidly connected to the Y-connector, the Y-connector coupled to the second coupler, and the third coupler configured to connect with the port of the channel of the medical device. [Item 15] the handle of the medical device is a first handle, and the body includes a first proximal portion including a second handle, a first distal portion, and a second proximal portion including the binding region, the second proximal portion of the body adapted to contact the first handle of the medical device; 15. The delivery device according to any one of items 1 to 14, wherein the first proximal portion, the second proximal portion, and the first distal portion form a U-shape with the first distal portion disposed between the first proximal portion and the second proximal portion, and the first proximal portion and the second proximal portion are disposed adjacent to each other and are connected via the first distal portion disposed between the first proximal portion and the second proximal portion. [Item 16] 16. The delivery device of any one of claims 1 to 15, further comprising an actuator including a trigger movably coupled to the body, and in response to pulling the actuator, the body, the drug source, and the pressurized fluid source are arranged to deliver pressurized fluid into the interior of the cylindrical portion of the drug source upstream through the funnel portion to move a mixture of the drug and the pressurized fluid within the drug source before moving the mixture out of the drug source and further toward the outlet port for delivery through the channel. [Item 17] The actuator is configured to move a pin relative to the body and engage the pressurized fluid source in response to selectively pulling the actuator, thereby piercing the pressurized fluid source and releasing pressurized fluid into the drug source. Item 17. The delivery device of item 16. Those skilled in the art will recognize that various modifications and variations can be made to the disclosed apparatus without departing from the scope of the present disclosure. Other embodiments of the present disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.

Claims

1. 1. A system comprising: The system includes a medical device including a catheter; The system includes a drug delivery device disposed external to the medical device and fluidly coupled to the catheter, the drug delivery device configured to store a drug and to deliver the drug to the medical device and into the catheter; The system includes a fluid delivery device disposed external to the medical device and fluidly coupled to the catheter, the fluid delivery device configured to store a fluid and to deliver the fluid into the catheter toward the medical device; The system is configured such that when the distal end of the catheter is positioned in the target tissue, the medical device is capable of delivering a drug received from the drug delivery device and a fluid received from the fluid delivery device to the target tissue via the catheter.

2. The system of claim 1 , wherein the drug is a multi-component drug comprising a first component drug and a second component drug.

3. The system of claim 2 , wherein the drug delivery device is configured to house each of the first component drug and the second component drug.

4. The system of claim 3 , wherein the drug delivery device is configured to allow the first component drug and the second component drug to be mixed together to generate a multi-component drug within the drug delivery device.

5. 5. The system of claim 4, wherein the drug delivery device is configured to mix the first component drug with the second component drug and deliver the multi-component drug to the medical device.

6. 10. The system of claim 1, wherein the drug delivery device includes a container for storing a drug and an actuator configured to selectively release the drug from the container for delivery outside of the drug delivery device.

7. The medical device includes a handle, a port in the handle, and the catheter extending distally from the handle; The system of claim 6 , wherein the port is in fluid communication with the catheter.

8. The system of claim 7 , wherein each of the medication delivery device and the fluid delivery device is fluidly coupled to the port of the handle via a connector.

9. The connector includes a Y-connector, 9. The system of claim 8, wherein the medication delivery device is fluidly coupled to the Y-connector via a first tube, the fluid delivery device is fluidly coupled to the Y-connector via a second tube, and the medical device is fluidly coupled to the Y-connector via a third tube.

10. The system of claim 8 , wherein the fluid delivery device comprises a syringe and the medical device comprises an endoscope.

11. 7. The system of claim 6, wherein the container includes a cylindrical portion and a funnel portion disposed downstream from the cylindrical portion, the cylindrical portion configured to store a medication and the funnel portion configured to receive the medication from the cylindrical portion by gravity.

12. The system of claim 1 , wherein the catheter includes a first channel and a second channel independent of the first channel.

13. 13. The system of claim 12, wherein the drug delivery device is fluidly coupled to the first channel of the catheter such that the medical device is configured to receive a drug from the drug delivery device through the first channel.

14. The system of claim 1 , wherein the fluid is configured to push a drug through the medical device and out of the catheter to deliver the drug to the target tissue.

15. 1. A system comprising: The system includes a medical device including a catheter; The system includes a drug delivery device fluidly coupled to the medical device via a first tube in fluid communication with the catheter, the drug delivery device including a drug stored therein, the drug delivery device configured, upon actuation, to deliver drug through the first tube and into the catheter towards the medical device; The system includes a fluid delivery device fluidly coupled to the medical device via a second tube in fluid communication with the catheter, the fluid delivery device including a fluid stored therein, the fluid delivery device configured, upon actuation, to deliver fluid into the catheter via the second tube and toward the medical device; The medical device is configured to receive and guide the drug and the fluid to a target tissue via the catheter.

16. the drug stored in the drug delivery device is a multi-component drug including at least a first component drug and a second component drug; 16. The system of claim 15, wherein the drug delivery device is configured to mix the first component drug with the second component drug to generate a multi-component drug, and deliver the multi-component drug through the first tube and into the catheter toward the medical device.

17. the first tube and the second tube are fluidly coupled to a connector, the connector being fluidly coupled to the medical device via a third tube; 16. The system of claim 15, wherein the drug received by the connector from the first tube and the fluid received by the connector from the second tube are each delivered from the connector to the medical device via the third tube.

18. the catheter includes at least a first channel and a second channel; 16. The system of claim 15, wherein the first channel is fluidly coupled to the first channel of the catheter such that the medical device receives a drug from the drug delivery device via the first channel.

19. The system of claim 15 , wherein the fluid is configured to push a drug through the medical device and out of the catheter to deliver the drug to the target tissue.

Images